Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 288

1.

The activity spectrum of Vif from multiple HIV-1 subtypes against APOBEC3G, APOBEC3F, and APOBEC3H.

Binka M, Ooms M, Steward M, Simon V.

J Virol. 2012 Jan;86(1):49-59. doi: 10.1128/JVI.06082-11. Epub 2011 Oct 19.

2.

A single amino acid difference in human APOBEC3H variants determines HIV-1 Vif sensitivity.

Zhen A, Wang T, Zhao K, Xiong Y, Yu XF.

J Virol. 2010 Feb;84(4):1902-11. doi: 10.1128/JVI.01509-09. Epub 2009 Nov 25.

3.

APOBEC3G and APOBEC3F Act in Concert To Extinguish HIV-1 Replication.

Krisko JF, Begum N, Baker CE, Foster JL, Garcia JV.

J Virol. 2016 Apr 14;90(9):4681-4695. doi: 10.1128/JVI.03275-15. Print 2016 May.

4.

The resistance of human APOBEC3H to HIV-1 NL4-3 molecular clone is determined by a single amino acid in Vif.

Ooms M, Letko M, Binka M, Simon V.

PLoS One. 2013;8(2):e57744. doi: 10.1371/journal.pone.0057744. Epub 2013 Feb 28.

5.

Identification of a critical T(Q/D/E)x5ADx2(I/L) motif from primate lentivirus Vif proteins that regulate APOBEC3G and APOBEC3F neutralizing activity.

Dang Y, Wang X, York IA, Zheng YH.

J Virol. 2010 Sep;84(17):8561-70. doi: 10.1128/JVI.00960-10. Epub 2010 Jun 30.

6.

Characterization of conserved motifs in HIV-1 Vif required for APOBEC3G and APOBEC3F interaction.

He Z, Zhang W, Chen G, Xu R, Yu XF.

J Mol Biol. 2008 Sep 12;381(4):1000-11. doi: 10.1016/j.jmb.2008.06.061. Epub 2008 Jun 28.

PMID:
18619467
7.

Mechanism of Enhanced HIV Restriction by Virion Coencapsidated Cytidine Deaminases APOBEC3F and APOBEC3G.

Ara A, Love RP, Follack TB, Ahmed KA, Adolph MB, Chelico L.

J Virol. 2017 Jan 18;91(3). pii: e02230-16. doi: 10.1128/JVI.02230-16. Print 2017 Feb 1.

8.

The Structural Interface between HIV-1 Vif and Human APOBEC3H.

Ooms M, Letko M, Simon V.

J Virol. 2017 Feb 14;91(5). pii: e02289-16. doi: 10.1128/JVI.02289-16. Print 2017 Mar 1.

9.

Mapping Region of Human Restriction Factor APOBEC3H Critical for Interaction with HIV-1 Vif.

Nakashima M, Tsuzuki S, Awazu H, Hamano A, Okada A, Ode H, Maejima M, Hachiya A, Yokomaku Y, Watanabe N, Akari H, Iwatani Y.

J Mol Biol. 2017 Apr 21;429(8):1262-1276. doi: 10.1016/j.jmb.2017.03.019. Epub 2017 Mar 21.

PMID:
28336404
10.

Dispersed sites of HIV Vif-dependent polyubiquitination in the DNA deaminase APOBEC3F.

Albin JS, Anderson JS, Johnson JR, Harjes E, Matsuo H, Krogan NJ, Harris RS.

J Mol Biol. 2013 Apr 12;425(7):1172-82. doi: 10.1016/j.jmb.2013.01.010. Epub 2013 Jan 11.

11.

APOBEC3G restricts HIV-1 to a greater extent than APOBEC3F and APOBEC3DE in human primary CD4+ T cells and macrophages.

Chaipan C, Smith JL, Hu WS, Pathak VK.

J Virol. 2013 Jan;87(1):444-53. doi: 10.1128/JVI.00676-12. Epub 2012 Oct 24.

12.

Distinct domains within APOBEC3G and APOBEC3F interact with separate regions of human immunodeficiency virus type 1 Vif.

Russell RA, Smith J, Barr R, Bhattacharyya D, Pathak VK.

J Virol. 2009 Feb;83(4):1992-2003. doi: 10.1128/JVI.01621-08. Epub 2008 Nov 26.

13.

Distinct determinants in HIV-1 Vif and human APOBEC3 proteins are required for the suppression of diverse host anti-viral proteins.

Zhang W, Chen G, Niewiadomska AM, Xu R, Yu XF.

PLoS One. 2008;3(12):e3963. doi: 10.1371/journal.pone.0003963. Epub 2008 Dec 17.

14.

Catalytic activity of APOBEC3F is required for efficient restriction of Vif-deficient human immunodeficiency virus.

Albin JS, Brown WL, Harris RS.

Virology. 2014 Feb;450-451:49-54. doi: 10.1016/j.virol.2013.11.041. Epub 2013 Dec 20.

17.

Differential anti-APOBEC3G activity of HIV-1 Vif proteins derived from different subtypes.

Iwabu Y, Kinomoto M, Tatsumi M, Fujita H, Shimura M, Tanaka Y, Ishizaka Y, Nolan D, Mallal S, Sata T, Tokunaga K.

J Biol Chem. 2010 Nov 12;285(46):35350-8. doi: 10.1074/jbc.M110.173286. Epub 2010 Sep 10.

18.

HIV-1 and HIV-2 Vif interact with human APOBEC3 proteins using completely different determinants.

Smith JL, Izumi T, Borbet TC, Hagedorn AN, Pathak VK.

J Virol. 2014 Sep 1;88(17):9893-908. doi: 10.1128/JVI.01318-14. Epub 2014 Jun 18.

19.

Identification of 81LGxGxxIxW89 and 171EDRW174 domains from human immunodeficiency virus type 1 Vif that regulate APOBEC3G and APOBEC3F neutralizing activity.

Dang Y, Davis RW, York IA, Zheng YH.

J Virol. 2010 Jun;84(11):5741-50. doi: 10.1128/JVI.00079-10. Epub 2010 Mar 24.

20.

Regulation of APOBEC3 proteins by a novel YXXL motif in human immunodeficiency virus type 1 Vif and simian immunodeficiency virus SIVagm Vif.

Pery E, Rajendran KS, Brazier AJ, Gabuzda D.

J Virol. 2009 Mar;83(5):2374-81. doi: 10.1128/JVI.01898-08. Epub 2008 Dec 24.

Supplemental Content

Support Center